Breaking News Instant updates and real-time market news.

MSFT

Microsoft

$104.45

-0.63 (-0.60%)

, ISRG

Intuitive Surgical

$525.36

-2.31 (-0.44%)

14:27
07/19/18
07/19
14:27
07/19/18
14:27

Notable companies reporting after market close

Notable companies reporting after the market close, with earnings consensus, include Microsoft (MSFT), consensus $1.08... Intuitive Surgical (ISRG), consensus $2.50... Capital One (COF), consensus $2.63... Cintas (CTAS), consensus $1.67... Skyworks Solutions (SWKS), consensus $1.60... E-TRADE (ETFC), consensus 88c... People's United Financial (PBCT), consensus 32c... Skechers (SKX), consensus 41c.

MSFT

Microsoft

$104.45

-0.63 (-0.60%)

ISRG

Intuitive Surgical

$525.36

-2.31 (-0.44%)

COF

Capital One

$95.69

-1.4 (-1.44%)

CTAS

Cintas

$193.16

0.62 (0.32%)

SWKS

Skyworks

$102.68

0.63 (0.62%)

ETFC

E-Trade

$61.35

-1.79 (-2.84%)

PBCT

People's United

$18.30

-0.04 (-0.22%)

SKX

Skechers

$33.25

0.62 (1.90%)

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 08

    Aug

  • 08

    Aug

  • 14

    Aug

  • 27

    Aug

  • 04

    Sep

MSFT Microsoft
$104.45

-0.63 (-0.60%)

07/18/18
FBCO
07/18/18
NO CHANGE
Target $115
FBCO
Outperform
Credit Suisse remains positive on Microsoft heading into Q4 results
Credit Suisse analyst Brad Zelnick remains positive on Microsoft heading into Q4 results. The analyst highlights incremental U.S. dollar strength since the time of last guidance, but is constructive on fundamental business drivers. Zelnick expects continued momentum in commercial cloud, driven by Azure growth and Office 365 strength. He reiterates an Outperform rating and $115 price target on the shares.
07/17/18
BOFA
07/17/18
NO CHANGE
Target $130
BOFA
Buy
Microsoft price target raised to $130 from $123 at BofA/Merrill
BofA/Merrill analyst Kash Rangan raised his price target for Microsoft to $130 from $123 as he expects a Q4 beat on revenues/EPS. His channel checks continue to suggest that potential upside opportunities exist long-term. The analyst believes E5 adoption could accelerate by end of CY2018 as market awareness of value proposition improves, while adoption trends should continue to be strong as feature sets good enough for enterprise wide deployments. Dynamics 365 is also seeing strong midmarket pull, he contends. Additionally, Rangan thinks gaming is underappreciated, but Fortnite could still be a tailwind. He reiterates a Buy rating on the shares.
07/18/18
SBSH
07/18/18
NO CHANGE
Target $300
SBSH
Buy
Nvidia can selloff near-term on graphics commentary, says Citi
Citi analyst Atif Malik says his recent supply chain checks indicate discrete graphics gaming demand is expected to remain sluggish thru the September quarter due to a "sharp decline" in mining related demand on falling cryptocurrency prices, channel distributors and partners waiting for Nvidia's (NVDA) new Turing gaming card launch in the October quarter, and weak gaming console sales at Microsoft (MSFT) offset by the Nintendo (NTDOY) Switch. The analyst lowered his July and October quarter estimates for Nvidia to bring them in-line with consensus. He thinks the stock can selloff in the near-term on weaker than expected graphics commentary from TSMC (TSM), who reports on July 19, and AMD (AMD), who reports on July 25. Malik, however, keeps a Buy rating on Nvidia with a $300 price target. He believes his long-term thesis on the shares remains intact.
07/18/18
KEYB
07/18/18
NO CHANGE
Target $110
KEYB
Overweight
Cyclical tailwinds could help lift Microsoft growth, says KeyBanc
KeyBanc analyst Brent Bracelin reiterates an Overweight rating and $110 price target for Microsoft as he believes it could benefit in the 2H from the combination of secular and cyclical tailwinds. The analyst sees Microsoft delivering double-digit revenue growth for the fourth consecutive quarter driven by healthy fundamentals across all three major segments and 40% secular growth in commercial cloud. While investor sentiment is mixed on moderating Azure growth, Bracelin thinks it this is misplaced given usage-based Azure growth could remain in the triple digits.
ISRG Intuitive Surgical
$525.36

-2.31 (-0.44%)

05/31/18
PIPR
05/31/18
NO CHANGE
Target $460
PIPR
Neutral
Intuitive Surgical shares to get lift on new FDA clearance, says Piper Jaffray
Though most expected clearance, Intuitive Surgical shares tomorrow will likely get a lift from the FDA approval for da Vinci Sp for urological procedures, Piper Jaffray analyst Matt O'Brien tells investors in a research note. Given the large number of inpatient invasive procedures of this kind, this will be a meaningful platform in the coming years, O'Brien adds. He keeps a Neutral rating on Intuitive Surgical, however, saying expectations are already quite high for the company to beat numbers.
06/05/18
CANT
06/05/18
NO CHANGE
Target $510
CANT
Overweight
Medtronic robot delay 'clear positive' for Intuitive Surgical, says Cantor
Medtronic (MDT) today at its analyst meeting said it expects commercial launch of its surgical robot in fiscal 2020, which is roughly a year delay compared to the company's prior expectations, Cantor Fitzgerald analyst Craig Bijou tells investors in a research note partially titled "ISRG's Headstart Gets Bigger." The analyst views the revised timing of the commercial launch of Medtronic's robot as a "clear positive" for Intuitive Surgical (ISRG). With the commercial launches of the Medtronic and Johnson & Johnson (JNJ) robots at least 18 months away, Intuitive should continue to grow its global installed base, further advancing its global surgical robotics leadership position, Bijou writes. He reiterates his Overweight rating on the shares with a $510 price target. The stock in afternoon trading is up $8.46 to $486.39.
06/18/18
PIPR
06/18/18
NO CHANGE
Target $96
PIPR
Overweight
Piper continues to recommend Medtronic after management meeting
After meeting with management, Piper Jaffray analyst Matt O'Brien continues to recommend building positions in Medtronic (MDT). The analyst views management's 4% plus revenue outlook over the next several years as "readily achievable and likely conservative." Management noted that given the low penetration rates of surgery performed on robots, they did not see a reason to be aggressive on pricing of their system once they get it to market, O'Brien tells investors in a research note. He believes that is a positive comment for Intuitive Surgical (ISRG). The analyst keeps an Overweight rating on Medtronic with a $96 price target.
06/27/18
BERN
06/27/18
INITIATION
Target $560
BERN
Outperform
Intuitive Surgical initiated with an Outperform at Bernstein
Bernstein analyst Lee Hambright started Intuitive Surgical with an Outperform rating and $560 as he believes it is a sustainable growth story. The analyst sees multiple durable growth drivers, namely U.S. hernia adoption, "catch-up" penetration OUS, and a strong new product cycle.
COF Capital One
$95.69

-1.4 (-1.44%)

07/13/18
BTIG
07/13/18
NO CHANGE
Target $44
BTIG
Buy
Synchrony may have 'upper hand' in Walmart credit card bidding, says BTIG
BTIG analyst Mark Palmer is keeping his Buy rating and $44 price target on Synchrony (SYF), noting the 5.3% decline in its stock price after media reports that Walmart (WMT) is considering shifting its credit card program to Capital One (COF). The analyst believes that Synchrony may still have the upper hand over Capital One because Walmart's objective to build out its digital wallet and mobile payment capabilities is better served by Synchrony's "understated solid experience helping retailers to develop their mobile capabilities" given its recent acquisition of GPShopper, which assists retailers in developing mobile apps. Palmer adds that given the risks and complexity around the transfer of a store-card program, Walmart should require a "very significant advantage", and it is more likely that it will renew its Synchony agreement at "somewhat less favorable terms for the issuer".
07/13/18
FBCO
07/13/18
NO CHANGE
Target $45
FBCO
Outperform
Synchrony 'unlikely' to lose Walmart contract, says Credit Suisse
Credit Suisse analyst Moshe Orenbuch said he believes Synchrony Financial (SYF) is likely to retain its credit card contract with Walmart (WMT) following a Bloomberg report that said Capital One (COF) is bidding for the portfolio. Orenbuch says this is "not an ideal partnership" for Capital One, because while it has been a long-time player in the nonprime card business, he feels it is "less likely" that it would be comfortable acquiring a large portfolio with potential significant nonprime component such as the Walmart portfolio, particularly when it did not underwrite the loans. Orenbuch says that if Synchrony does retain the contract, which is expected to expire in 2019, the company will most likely have to cede more economics to Walmart in terms of profit sharing.
07/13/18
SUSQ
07/13/18
NO CHANGE
SUSQ
Susquehanna says Walmart card flip could be loss for First Data, win for TSYS
After Bloomberg reported yesterday that Capital One (COF) is bidding to issue Walmart's (WMT) private-label card and replace incumbent Synchrony (SYF), Susquehanna analyst James Friedman noted that TSYS (TSS) is used by Capitol One for its issuer processing, while First Data (FDC) processes for Synchrony. If TSYS were to win the issuer processing business of the Walmart cards via a successful Capital One bid, Friedman estimates it could represent revenue upside of $11M-$15M. The firm has Positive ratings on First Data, Synchrony and TSYS.
07/13/18
SPHN
07/13/18
NO CHANGE
Target $100
SPHN
Overweight
Stephens says Walmart move to Capital One cards would be opportunity for TSYS
After Bloomberg reported yesterday that Walmart (WMT) is considering moving its private-label and or co-brand card portfolios to Capital One (COF) from incumbent Synchrony (SYF), Stephens analyst Brett Huff called the potential switch an possible opportunity for TSYS (TSS), which he notes is the card issuer processor for Capital One. He estimates this move, if it happens, could represent about a $15M revenue opportunity for TSYS. Huff keeps an Overweight rating and $100 price target on TSYS shares.
CTAS Cintas
$193.16

0.62 (0.32%)

03/27/18
GSCO
03/27/18
INITIATION
Target $210
GSCO
Conviction Buy
Cintas initiated with a Conviction Buy at Goldman Sachs
Goldman Sachs analyst George Tong started Cintas with a Conviction Buy rating and $210 price target. The analyst rolled out coverage on the Americas Business Services sector with an Attractive rating.
01/25/18
BARD
01/25/18
NO CHANGE
Target $185
BARD
Outperform
Cintas long-term opportunity remains significant, says Baird
Baird analyst Andrew Wittmann believes Cintas' long-term opportunity remains significant with plenty of small items likely adding up to big share gains and strong financial returns over time. He believes the company's executive and operations-level management remain underappreciated and their execution will further separate them from the competition. Wittmann reiterated his Outperform rating and $185 price target on Cintas shares.
12/22/17
BARD
12/22/17
NO CHANGE
Target $185
BARD
Outperform
Cintas price target raised to $185 from $165 at Baird
Baird analyst Andrew Wittman raised his price target on Cintas to $185 from $165 following another solid beat. The analyst noted solid organic gains and gross margins, the on-track integration of G&K Services and solid long-term potential. He sees solid fundamentals and the company's competitive moat widening. Wittman reiterated his Outperform rating on Cintas shares.
12/22/17
JPMS
12/22/17
NO CHANGE
Target $183
JPMS
Overweight
Cintas price target raised to $183 from $160 at JPMorgan
JPMorgan analyst Andrew Steinerman raised his price target for Cintas to $183 saying the company's "impressive" momentum continues Wednesday night's beat and raise quarter. The analyst keeps an Overweight rating on the shares.
SWKS Skyworks
$102.68

0.63 (0.62%)

07/12/18
LOOP
07/12/18
NO CHANGE
Target $130
LOOP
Buy
Skyworks to deliver 'stable, in-line' Q3 results, says Loop Capital
Loop Capital analyst Cody Acree kept his Buy rating and $130 price target on Skyworks ahead of its Q3 earnings next week, saying that with much of the industry's excess smartphone inventory cleared, the company is positioned to "deliver stable in-line Q3 results". The analyst also cites the benefits of stronger Skyworkds' Broad Markets boosted by WiFi, automotive, and Internet of Things industry demand. Acree further anticipates "at least modest upside" in its Q4 guidance to reflect the seasonal build cycle at Apple and its new low-band PAD win.
06/12/18
KEYB
06/12/18
NO CHANGE
KEYB
Apple iPhone inventories normalize, Galaxy S9 continue to disappoint, says KeyBanc
KeyBanc analyst John Vinh says his latest carrier surveys indicate stable sell-through of Apple's (AAPL) iPhone 8/X, and in line with store expectations. Accordingly, days of inventory have normalized at about 5 DOI and are consistent with healthy levels seen in past cycles, he adds. Conversely, the analyst notes that sell-through of the Samsung's (SSNLF) GS9 continues to deteriorate, accompanied by an increase in DOI. However, he notes a significant reduction in absolute inventories. While GS9 gives him pause, stable sell-through, and normalized iPhone 8/X inventories leave him incrementally more constructive ahead of the 2H ramp of the new iPhone 9 cycle. Vihn recommends investors continue to own Broadcom (AVGO), Skyworks (SWKS), and Synaptics (SYNA).
06/15/18
BNCH
06/15/18
INITIATION
Target $114
BNCH
Buy
Skyworks initiated with a Buy at Benchmark
Benchmark started Skyworks with a Buy rating and $114 price target. The firm views the company as an "attractive cash flow engine" with balance sheet optionality.
06/21/18
LOOP
06/21/18
INITIATION
Target $130
LOOP
Buy
Skyworks initiated with a Buy at Loop Capital
Loop Capital analyst Cody Acree initiated Skyworks with a Buy rating and $130 price target, stating that he views it as one of the companies best positioned to capitalize on its leadership in the smartphone market.
ETFC E-Trade
$61.35

-1.79 (-2.84%)

04/20/18
RHCO
04/20/18
NO CHANGE
Target $70
RHCO
Buy
E-Trade price target raised to $70 from $66 at SunTrust
SunTrust analyst Douglas Mewhirter raised his price target on E-Trade to $70 after the company's "strong" Q1 results showing better than expected revenues from accelerated investments along with better net interest margins and "another loan loss reserve reversal". Mewhirter also raised his FY18 EPS to $3.70 from $3.27 on higher net interest margin forecasts, adding that his new price target reflects unchanged 19-times multiple for expected FY18 earnings. The analyst keeps his Buy rating on E-Trade.
05/21/18
WELS
05/21/18
NO CHANGE
Target $73
WELS
Outperform
E-Trade price target raised to $73 from $67 at Wells Fargo
Wells Fargo analyst Christopher Harris raised his price target for E-Trade to $73 from $67 saying he remains bullish on the shares as he sees the current valuation as hardly stretched, consensus EPS as much too low and the operating environment as remaining constructive. The analyst reiterates an Outperform rating on the shares.
05/31/18
UBSW
05/31/18
NO CHANGE
Target $73
UBSW
Buy
E-Trade price target raised to $73 from $67 at UBS
UBS analyst Brennan Hawkin raised his price target on E-Trade to $73 from $67 as he believes the stakes have been raised for a potential buyout. The analyst said the probability remains unclear but a deal with peers is probably most attractive, although he does not rule out a bank or broker. His increased price target reflects some takeout premium given the active bidding process, noted Hawkin, who reiterated his Buy rating on E-Trade shares.
06/04/18
COMP
06/04/18
INITIATION
Target $72
COMP
Buy
E-Trade initiated with a Buy at Compass Point
Compass Point initiated E-Trade with a Buy and $72 price target.
PBCT People's United
$18.30

-0.04 (-0.22%)

06/27/18
KBWI
06/27/18
UPGRADE
Target $37
KBWI
Outperform
First Connecticut upgraded to Outperform with $37 target at Keefe Bruyette
Keefe Bruyette analyst Damon DelMonte upgraded First Connecticut Bancorp (FBNK) to Outperform from Market Perform and raised his price target for the shares to $37 from $29. The analyst aligned his target and valuation with People's United Financial (PBCT) as a result of the pending merger between the two banks.
06/19/18
KBWI
06/19/18
UPGRADE
KBWI
Outperform
People's United upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Collyn Gilbert upgraded People's United Financial (PBCT) to Outperform with an unchanged price target of $21.50. The recent selloff in the shares implies a 20% total return, Gilbert tells investors in a research note. The analyst thinks the outlook for People's fundamental improvement relative to its current valuation "finally warrants more active investor attention." Gilbert views the First Connecticut Bancorp (FBNK) acquisition favorably.
04/20/18
PIPR
04/20/18
UPGRADE
Target $18
PIPR
Neutral
People's United upgraded to Neutral from Underweight at Piper Jaffray
Piper Jaffray analyst Matthew Breese upgraded People's United Financial to Neutral with an unchanged price target of $18. The analyst believes the shares are nearing fair value following yesterday's post-earnings pullback. He no longer expects the stock to underperform over the next 12 months.
04/19/18
SDLR
04/19/18
UPGRADE
Target $21
SDLR
Buy
People's United upgraded to Buy from Hold at Sandler O'Neill
Sandler O'Neill analyst Mark Fitzgibbon upgraded People's United Financial to Buy with a $21 price target following the company's Q1 results.
SKX Skechers
$33.25

0.62 (1.90%)

04/20/18
04/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Neutral from Buy at BofA/Merrill and to Hold from Buy at Deutsche Bank aw well as Argus. 2. Philip Morris (PM) downgraded to Buy from Conviction Buy at Goldman Sachs and to Underperform from Neutral at BofA/Merrill. 3. DHT Holdings (DHT) downgraded to Neutral from Overweight at JPMorgan with analyst Noah Parquette saying he has become more constructive on a crude tanker recovery in 2019 but cites relative valuation for the downgrade on DHT. 4. Skechers (SKX) downgraded to Neutral from Outperform at Wedbush with analyst Christopher Svezia citing the company's first quarter results. 5. Tyson Foods (TSN) downgraded to Hold from Buy at Vertical Group. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/21/18
UBSW
06/21/18
INITIATION
Target $42
UBSW
Buy
Skechers initiated with a Buy at UBS
UBS analyst Jay Sole started Skechers with a Buy rating and $42 price target.
07/12/18
BUCK
07/12/18
NO CHANGE
Target $42
BUCK
Buy
Buckingham checks suggest healthy demand for Skechers
Buckingham analyst Eric Tracy reiterates a Buy rating and $42 price target for Skechers following positive industry checks and into next week's Q2 results. His checks/discussions with recent industry contacts suggest demand remains healthy/product pipeline evolving nicely, supportive of 2H top line reacceleration, in his view. Tracy believes investments likely mute FY18 EPS upside, with greater opportunities for improved leverage in FY19.
04/20/18
SUSQ
04/20/18
NO CHANGE
Target $40
SUSQ
Positive
Skechers price target lowered to $40 from $52 at Susquehanna
Susquehanna analyst Sam Poser lowered his price target on Skechers to $40 from $52 following Q1 results. He noted the company delivered a slight beat driven by revenues and gross margins but offset by SG&A. He said he would buy the shares on the recent pullback, citing strong demand for its brand. Poser reiterated his Positive rating on Skechers shares.

TODAY'S FREE FLY STORIES

CCF

Chase Corporation

$100.72

0.32 (0.32%)

17:32
05/23/19
05/23
17:32
05/23/19
17:32
Hot Stocks
Chase Corporation chairman sells 2K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNR

RenaissanceRe

$170.85

-0.34 (-0.20%)

17:24
05/23/19
05/23
17:24
05/23/19
17:24
Syndicate
Breaking Syndicate news story on RenaissanceRe »

RenaissanceRe files $750M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

17:21
05/23/19
05/23
17:21
05/23/19
17:21
Syndicate
Breaking Syndicate news story on RTI Surgical »

RTI Surgical files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 17

    Jun

DXC

DXC Technology

$52.00

-2.5 (-4.59%)

17:21
05/23/19
05/23
17:21
05/23/19
17:21
Earnings
DXC Technology sees FY20 adjusted EPS $7.75-$8.50, consensus $9.21 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

17:19
05/23/19
05/23
17:19
05/23/19
17:19
Syndicate
Breaking Syndicate news story on RTI Surgical »

RTI Surgical files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 17

    Jun

RTN

Raytheon

$179.79

-1.01 (-0.56%)

17:15
05/23/19
05/23
17:15
05/23/19
17:15
Hot Stocks
Raytheon awarded $355.49M Navy contract for AGM-88B missiles »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

DVAX

Dynavax

$6.36

(0.00%)

17:15
05/23/19
05/23
17:15
05/23/19
17:15
Hot Stocks
Breaking Hot Stocks news story on Dynavax 

Dynavax trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

COST

Costco

$248.62

-0.93 (-0.37%)

17:11
05/23/19
05/23
17:11
05/23/19
17:11
Recommendations
Costco analyst commentary  »

Baird recommends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

MYND

MYnd Analytics

$1.16

0.14 (13.73%)

17:06
05/23/19
05/23
17:06
05/23/19
17:06
Hot Stocks
MYnd Analytics director John Pappajohn purchases 200K shares of company stock »

MYnd Analytics director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBOE

Cboe Global Markets

$106.40

-1.45 (-1.34%)

17:05
05/23/19
05/23
17:05
05/23/19
17:05
Hot Stocks
Cboe Global Markets EVP Harkins sells 4.3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGNX

MacroGenics

$18.64

0.18 (0.98%)

16:56
05/23/19
05/23
16:56
05/23/19
16:56
Hot Stocks
Integrated Core Strategies reports 5.7% passive stake in MacroGenics »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

IMRN

Immuron

$4.90

(0.00%)

16:49
05/23/19
05/23
16:49
05/23/19
16:49
Syndicate
Immuron announces offering to sell ADSs »

Immuron Limited announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROLL

RBC Bearings

$140.52

1.84 (1.33%)

16:47
05/23/19
05/23
16:47
05/23/19
16:47
Hot Stocks
RBC Bearings announces $100M share repurchase program »

RBC Bearings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 05

    Jun

DVAX

Dynavax

$6.36

(0.00%)

16:47
05/23/19
05/23
16:47
05/23/19
16:47
Hot Stocks
Dynavax to restructure to focus on vaccine business »

Dynavax Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

CNC

Centene

$55.45

-1.33 (-2.34%)

, WCG

WellCare

$274.46

-3.54 (-1.27%)

16:45
05/23/19
05/23
16:45
05/23/19
16:45
Hot Stocks
Centene, WellCare announce special meeting date, transaction to close by 1H20 »

Centene (CNC) and…

CNC

Centene

$55.45

-1.33 (-2.34%)

WCG

WellCare

$274.46

-3.54 (-1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 23

    Jul

DVAX

Dynavax

$6.36

(0.00%)

16:42
05/23/19
05/23
16:42
05/23/19
16:42
Hot Stocks
Breaking Hot Stocks news story on Dynavax »

Dynavax trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

DNKEY

Danske Bank

$0.00

(0.00%)

16:39
05/23/19
05/23
16:39
05/23/19
16:39
Downgrade
Danske Bank rating change at Goldman Sachs »

Danske Bank downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WD

Walker & Dunlop

$51.59

-0.92 (-1.75%)

16:39
05/23/19
05/23
16:39
05/23/19
16:39
Hot Stocks
Walker & Dunlop President Howard Smith sells $4M in company shares »

Walker & Dunlop…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TD

Toronto-Dominion

$56.01

1.05 (1.91%)

16:36
05/23/19
05/23
16:36
05/23/19
16:36
Downgrade
Toronto-Dominion rating change at National Bank »

Toronto-Dominion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

16:36
05/23/19
05/23
16:36
05/23/19
16:36
General news
Money Supply M2 Weekly Change data reported »

Week of 5/13 Money Supply…

GWGH

GWG Holdings

$15.25

0.05 (0.33%)

16:36
05/23/19
05/23
16:36
05/23/19
16:36
Hot Stocks
GWG Holdings receives noncompliance notification from Nasdaq »

GWG Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSA

National Storage

$29.80

-0.195 (-0.65%)

16:35
05/23/19
05/23
16:35
05/23/19
16:35
Hot Stocks
National Storage 'elevates' its CEO Arlen Nordhagen to Executive Chairman »

National Storage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 04

    Jun

16:34
05/23/19
05/23
16:34
05/23/19
16:34
General news
Fed Balance Sheet Level data reported »

Week of 5/22 Fed Balance…

MOS

Mosaic

$21.62

-0.72 (-3.22%)

16:32
05/23/19
05/23
16:32
05/23/19
16:32
Hot Stocks
Mosaic doubles quarterly dividend to 5c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 13

    Nov

ATIS

Attis Industries

$2.15

0.31 (16.85%)

16:32
05/23/19
05/23
16:32
05/23/19
16:32
Hot Stocks
Attis Industries notified by Nasdaq of delinquent Q1 10-Q filing »

Attis Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.